Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The value in rows (5) and (7) represents 7,521,300 shares of common stock of record by Bonita Biotech (HK) Limited. Bonita Biotech (HK) Limited is wholly owned by Biosion, Inc. (2) Percent of class represented by amount in row (9) is calculated based on 158,612,149 issued and outstanding shares of Common Stock of the Issuer as at October 30, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The value in rows (5) and (7) represents 7,521,300 shares of common stock of record by Bonita Biotech (HK) Limited. (2) Percent of class represented by amount in row (9) is calculated based on 158,612,149 issued and outstanding shares of Common Stock of the Issuer as at October 30, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 5, 2026.


SCHEDULE 13G



 
Biosion, Inc.
 
Signature:/s/ MINGJIU CHEN
Name/Title:MINGJIU CHEN / CEO
Date:11/16/2026
 
Bonita Biotech (HK) Ltd
 
Signature:/s/ MINGJIU CHEN
Name/Title:MINGJIU CHEN / Director
Date:11/16/2026